Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/06/22
End: 07/31/24
Due: 07/31/25
Phase: N/A
Priority: Normal
Start: 03/22/22
End: 02/28/25
Due: 02/28/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A First-in-Human Study to Assess Single Doses of APNmAb005 in Healthy Participants | NCT05344989 | APRINOIA Therapeutics, LLC | user2@example.com | None | 2022-05-06 | 2024-07-31 | 2025-07-31 | - | - | 2025-07-14 |
| Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients Compared With Healthy Subjects | NCT04141150 | APRINOIA Therapeutics, LLC | user2@example.com | None | 2022-03-22 | 2025-02-28 | 2026-02-28 | - | - | 2025-07-14 |